Moolec Science (MLEC) Inventory Average (2023 - 2026)
Moolec Science (MLEC) reported Inventory Average of $3.8 million for Q1 2026, up 21.88% sequentially from $3.1 million in Q4 2025.
Moolec Science (MLEC) Inventory Average (2023 - 2026) Analysis & Trends
Moolec Science (MLEC) has 4 years of Inventory Average data on file, last reported at $3.8 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average changed N/A year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (changed N/A YoY), and the FY2025 full-year result was $64.1 million, down 46.13% from the prior year.
- Inventory Average improved to $3.8 million in Q1 2026, from $3.1 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $65.8 million in Q3 2024 to a low of $444234.0 in Q1 2024.
- A 4-year average of $25.8 million and a median of $4.5 million in 2024 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average jumped 1068.59% in 2024 and plunged 94.39% in 2025, its largest moves.
- Tracing MLEC's Inventory Average over 4 years: stood at $445937.5 in 2023, then jumped by 1068.59% to $5.2 million in 2024, then tumbled by 40.17% to $3.1 million in 2025, then increased by 21.88% to $3.8 million in 2026.
- Business Quant data shows MLEC's Inventory Average at $3.8 million in Q1 2026, $3.1 million in Q4 2025, and $3.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | - |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn | 644.91 Mn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | 3.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.80 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Dec 31, 2024 | 5.21 Mn |
| Sep 30, 2024 | 65.75 Mn |
| Jun 30, 2024 | 63.16 Mn |
| Mar 31, 2024 | 444,234.00 |
| Dec 31, 2023 | 445,937.50 |
| Sep 30, 2023 | 56.20 Mn |
| Jun 30, 2023 | 56.27 Mn |